Physician

Charles Riley Latham, D.O.

According to 2025 Medicare claims, Charles Latham, D.O. (NPI: 1780064501) practices family practice in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Amherst, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24572-3001. Latham is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Latham's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 518 traditional Medicare patients, billed 14,248 HCPCS/CPT codes, and received $353,590 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 12,821 prescription claims across 783 beneficiaries totaling $1,032,176 in drug costs, led by Jardiance (Empagliflozin). DME data shows 548 claims. Open Payments data shows 166 records totaling $2,457. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $82,901 to $353,590. Similarly, Part D prescription costs have moved sharply higher in recent years, from $6,886 to $1,032,176. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $1,552 to $49,136.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	339	2,969	$82,901
2019	597	8,462	$217,604
2020	546	8,103	$213,771
2021	516	7,432	$212,973
2022	473	6,980	$202,613
2023	504	13,615	$333,413
2024	518	14,248	$353,590

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	21	71	$6,886
2016	63	413	$31,644
2017	112	887	$53,344
2018	505	2,313	$137,563
2019	604	7,828	$526,744
2020	594	8,835	$602,995
2021	568	8,674	$560,532
2022	578	8,755	$610,951
2023	1,076	11,133	$957,922
2024	783	12,821	$1,032,176

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	11	$212
2017	N/R	17	$104
2018	N/R	12	$98
2019	56	260	$3,894
2020	66	325	$10,875
2021	92	434	$15,814
2022	66	320	$15,051
2023	112	471	$23,530
2024	120	548	$25,266

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	484	1,242	$81
80061	Blood test, lipids (cholesterol and triglycerides)	476	935	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	439	918	$11
80053	Blood test, comprehensive group of blood chemicals	439	493	$10
36415	Insertion of needle into vein for collection of blood sample	480	1,192	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	97	6,580	$123,664
Farxiga	Dapagliflozin Propanediol	139	6,710	$121,005
Eliquis	Apixaban	108	5,714	$111,230
Januvia	Sitagliptin Phosphate	74	4,260	$77,693
Ozempic	Semaglutide	51	2,338	$69,120

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	36	$11,108
E0601	Continuous positive airway pressure (cpap) device	Y	11	82	$2,495
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	31	$2,113
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	12	29	$1,479
A7031	Face mask interface, replacement for full face mask, each	N	N/R	18	$1,462

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	166	$2,457	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Charles Riley Latham, D.O.?

Tedicare shows public-source Medicare data for Charles Riley Latham, D.O. (NPI 1780064501), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Charles Riley Latham, D.O. have ACO affiliation data?

Charles Riley Latham, D.O. is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to Charles Riley Latham, D.O.?

Charles Riley Latham, D.O. is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does Charles Riley Latham, D.O. have Open Payments data?

Charles Riley Latham, D.O. has 166 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.